Cytomegalovirus-specific T cells are detectable in early childhood and allow assignment of the infection status in children with passive maternal antibodies

European Journal of Immunology

Volumn 43, Issue 4, 2013, Pages 1099-1108

  Ritter, Marion ^a   Schmidt, Tina ^a   Dirks, Jan ^a   Hennes, Pia ^a   Juhasz Böss, Ingolf ^a   Solomayer, Erich F ^a   Gortner, Ludwig ^a   Gärtner, Barbarac ^a   Rohrer, Tilman ^a   Sester, Urban ^a   Sester, Martina ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Cytokine profiling; Maternal antibodies; Neonatal immunity; Passive immunity; Transplantation

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; MATERNAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ANTIBODY PRODUCTION; ARTICLE; CD4+ T LYMPHOCYTE; CELL SPECIFICITY; CELL STIMULATION; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; EFFECTOR CELL; FEMALE; GROUPS BY AGE; HUMAN; HUMAN CELL; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SEROLOGY; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; CYTOKINES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; INTERFERON-GAMMA; MALE; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH17 CELLS;

EID: 84876447960     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201243100     Document Type: Article

References (40)

1. Kotton, C. N., Kumar, D., Caliendo, A. M., Asberg, A., Chou, S., Snydman, D. R., Allen, U. et al., International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2010. 89: 779-795.
2. Martin, J. M. and Danziger-Isakov, L. A., Cytomegalovirus risk, prevention, and management in pediatric solid organ transplantation. Pediatr. Transplant. 2011. 15: 229-236.
3. Allen, U. D., Current status and impact of CMV prevention following pediatric organ transplantation. Pediatr. Transplant. 2008. 12: 389-392.
4. Sester, M., Gärtner, B. C., Sester, U., Girndt, M., Mueller-Lantzsch, N. and Köhler, H., Is the CMV serologic status always accurate? A comparative analysis of humoral and cellular immunity. Transplantation 2003. 76: 1229-1231.
5. Sester, M., Gärtner, B. C. and Sester, U., Monitoring of CMV specific T-cell levels after organ transplantation. J. Lab. Med. 2008. 32: 121-130.
6. Schmidt, T., Ritter, M., Dirks, J., Gartner, B. C., Sester, U. and Sester, M., Cytomegalovirus-specific T-cell immunity to assign the infection status in individuals with passive immunity: a proof of principle. J. Clin. Virol. 2012. 54: 272-275.
7. Prendergast, A. J., Klenerman, P. and Goulder, P. J., The impact of differential antiviral immunity in children and adults. Nat. Rev. Immunol. 2012. 12: 636-648.
8. Leuridan, E. and Van Damme, P., Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns. Vaccine 2007. 25: 6296-6304.
9. Gillespie, G. M., Wills, M. R., Appay, V., O'Callaghan, C., Murphy, M., Smith, N., Sissons, P. et al., Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors. J. Virol. 2000. 74: 8140-8150.
10. Khan, N., Shariff, N., Cobbold, M., Bruton, R., Ainsworth, J. A., Sinclair, A. J., Nayak, L. et al., Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J. Immunol. 2002. 169: 1984-1992.
11. Sester, M., Sester, U., Gärtner, B., Heine, G., Girndt, M., Mueller-Lantzsch, N., Meyerhans, A. et al., Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation 2001. 71: 1287-1294.
12. Sester, U., Gärtner, B. C., Wilkens, H., Schwaab, B., Wössner, R., Kindermann, I., Girndt, M. et al., Differences in CMV-specific T-cell levels and long-term susceptibility to CMV infection after kidney, heart and lung transplantation. Am. J. Transplant. 2005. 5: 1483-1489.
13. Sester, U., Presser, D., Dirks, J., Gärtner, B. C., Köhler, H. and Sester, M., PD-1 expression and IL-2 loss of cytomegalovirus-specific T cells correlates with viremia and reversible functional anergy. Am. J. Transplant. 2008. 8: 1486-1497.
14. Pourgheysari, B., Khan, N., Best, D., Bruton, R., Nayak, L. and Moss, P. A., The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire. J. Virol. 2007. 81: 7759-7765.
15. Tu, W., Chen, S., Sharp, M., Dekker, C., Manganello, A. M., Tongson, E. C., Maecker, H. T. et al., Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children. J. Immunol. 2004. 172: 3260-3267.
16. Komatsu, H., Inui, A., Sogo, T., Fujisawa, T., Nagasaka, H., Nonoyama, S., Sierro, S. et al., Large scale analysis of pediatric antiviral CD8+ T cell populations reveals sustained, functional and mature responses. Immun. Ageing 2006. 3: 11.
17. Appay, V., Dunbar, P. R., Callan, M., Klenerman, P., Gillespie, G. M., Papagno, L., Ogg, G. S. et al., Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 2002. 8: 379-385.
18. Miles, D. J., van der Sande, M., Jeffries, D., Kaye, S., Ismaili, J., Ojuola, O., Sanneh, M. et al., Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation. J. Virol. 2007. 81: 5766-5776.
19. Nebbia, G., Mattes, F. M., Smith, C., Hainsworth, E., Kopycinski, J., Burroughs, A., Griffiths, P. D. et al., Polyfunctional cytomegalovirus-specific CD4+ and pp65 CD8+ T cells protect against high-level replication after liver transplantation. Am. J. Transplant. 2008. 8: 2590-2599.
20. Cannon, M. J., Hyde, T. B. and Schmid, D. S., Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Rev. Med. Virol. 2011. 21: 240-255.
21. Derhovanessian, E., Maier, A. B., Hahnel, K., Beck, R., de Craen, A. J., Slagboom, E. P., Westendorp, R. G. et al., Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4+ and CD8+ T-cells in humans. J. Gen. Virol. 2011. 92: 2746-2756.
22. Derhovanessian, E., Larbi, A. and Pawelec, G., Biomarkers of human immunosenescence: impact of Cytomegalovirus infection. Curr. Opin. Immunol. 2009. 21: 440-445.
23. Ben-Smith, A., Gorak-Stolinska, P., Floyd, S., Weir, R. E., Lalor, M. K., Mvula, H., Crampin, A. C. et al., Differences between naive and memory T cell phenotype in Malawian and UK adolescents: a role for Cytomegalovirus? BMC Infect Dis. 2008. 8: 139.
24. Mack, U., Migliori, G. B., Sester, M., Rieder, H. L., Ehlers, S., Goletti, D., Bossink, A. et al., LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur. Respir. J. 2009. 33: 956-973.
25. Basu Roy, R., Sotgiu, G., Altet-Gomez, N., Tsolia, M., Ruga, E., Velizarova, S. and Kampmann, B., Identifying predictors of interferon-gamma release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin? A pTB-NET collaborative study. Am. J. Respir. Crit. Care Med. 2012. 186: 378-384.
26. Markova, R., Drenska, R., Minchev, P., Todorova, Y., Ciccozzi, M. and Amicosante, M., Association of age with the level of response in the QuantiFERON-TB Gold In-Tube assay for children with active tuberculosis. New Microbiol. 2011. 34: 81-85.
27. Kampmann, B., Whittaker, E., Williams, A., Walters, S., Gordon, A., Martinez-Alier, N., Williams, B. et al., Interferon-gamma release assays do not identify more children with active tuberculosis than the tuberculin skin test. Eur. Respir. J. 2009. 33: 1374-1382.
28. Detjen, A. K., Keil, T., Roll, S., Hauer, B., Mauch, H., Wahn, U. and Magdorf, K., Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin. Infect Dis. 2007. 45: 322-328.
29. Lighter, J., Rigaud, M., Eduardo, R., Peng, C. H. and Pollack, H., Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test. Pediatrics 2009. 123: 30-37.
30. Haustein, T., Ridout, D. A., Hartley, J. C., Thaker, U., Shingadia, D., Klein, N. J., Novelli, V. et al., The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr. Infect Dis. J. 2009. 28: 669-673.
31. Bergamini, B. M., Losi, M., Vaienti, F., D'Amico, R., Meccugni, B., Meacci, M., De Giovanni, D. et al., Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents. Pediatrics 2009. 123: e419-e424.
32. Ferrara, G., Losi, M., D'Amico, R., Roversi, P., Piro, R., Meacci, M., Meccugni, B. et al., Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006. 367: 1328-1334.
33. Lagrou, K., Bodeus, M., Van Ranst, M. and Goubau, P., Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays. J. Clin. Microbiol. 2009. 47: 1695-1699.
34. Adler, S. P., Cytomegalovirus transmission and child day care. Adv. Pediatr. Infect Dis. 1992. 7: 109-122.
35. Schlesinger, Y., Halle, D., Eidelman, A. I., Reich, D., Dayan, D., Rudensky, B., Raveh, D. et al., Urine polymerase chain reaction as a screening tool for the detection of congenital cytomegalovirus infection. Arch. Dis. Child Fetal Neonatal Ed. 2003. 88: F371-F374.
36. Melish, M. E. and Hanshaw, J. B., Congenital cytomegalovirus infection. Developmental progress of infants detected by routine screening. Am. J. Dis. Child. 1973. 126: 190-194.
37. Vilibic-Cavlek, T., Ljubin-Sternak, S., Vojnovic, G., Sviben, M. and Mlinaric-Galinovic, G., The role of IgG avidity in diagnosis of cytomegalovirus infection in newborns and infants. Coll. Antropol. 2012. 36: 297-300.
38. Patel, M., Stefanidou, M., Long, C. B., Fazzari, M. J., Tesfa, L., Del Rio, M., Lamour, J. et al., Dynamics of cell-mediated immune responses to cytomegalovirus in pediatric transplantation recipients. Pediatr. Transplant. 2012. 16: 18-28.
39. Schmidt, T., Dirks, J., Enders, M., Gartner, B. C., Uhlmann-Schiffler, H., Sester, U. and Sester, M., CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection. Eur. J. Immunol. 2012. 42: 1755-1766.
40. Landis, J. R. and Koch, G. G., The measurement of observer agreement for categorical data. Biometrics 1977. 33: 159-174.